SEC Form 4 · accession 0001645627-17-000098
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 20, 2017
Accepted (ET)
Jul 24, 2017 · 3:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0219 | A | 21,876,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0219 | A | 21,878,389 | D | |
| Common Stock | Jul 20, 2017 | P | 5,000 | $0.0219 | A | 21,883,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0212 | A | 21,885,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0218 | A | 21,887,389 | D | |
| Common Stock | Jul 20, 2017 | P | 5,000 | $0.0195 | A | 21,892,389 | D | |
| Common Stock | Jul 20, 2017 | P | 5,000 | $0.0195 | A | 21,897,389 | D | |
| Common Stock | Jul 20, 2017 | P | 5,000 | $0.0195 | A | 21,902,389 | D | |
| Common Stock | Jul 20, 2017 | P | 5,000 | $0.0183 | A | 21,907,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0183 | A | 21,909,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0182 | A | 21,911,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0182 | A | 21,913,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0182 | A | 21,915,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.02 | A | 21,917,389 | D | |
| Common Stock | Jul 20, 2017 | P | 5,000 | $0.0191 | A | 21,922,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0194 | A | 21,924,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0195 | A | 21,926,389 | D | |
| Common Stock | Jul 20, 2017 | P | 10,000 | $0.0195 | A | 21,936,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.02 | A | 21,938,389 | D | |
| Common Stock | Jul 20, 2017 | P | 5,000 | $0.0216 | A | 21,943,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0213 | A | 21,945,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0214 | A | 21,947,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0216 | A | 21,949,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0215 | A | 21,951,389 | D | |
| Common Stock | Jul 20, 2017 | P | 5,000 | $0.0215 | A | 21,956,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0216 | A | 21,958,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0216 | A | 21,960,389 | D | |
| Common Stock | Jul 20, 2017 | P | 2,000 | $0.0216 | A | 21,962,389 | D | |
| Common Stock | Jul 21, 2017 | P | 2,000 | $0.0214 | A | 21,964,389 | D | |
| Common Stock | Jul 21, 2017 | P | 2,000 | $0.0214 | A | 21,966,389 | D |
Table II — derivative securities
No Table II lines on this filing.